Vimarsana
Biggest News Aggregation in the World

Page 29 - Crispr News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Crispr. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Crispr Today - Breaking & Trending Today

Opinion | A New Sickle Cell Treatment Will Change Lives — but How Many? - Vimarsana News

Opinion | A New Sickle Cell Treatment Will Change Lives — but How Many?

A new treatment for sickle cell disease will change lives — but how many?

FDA to consider first CRISPR therapy - Vimarsana News

FDA to consider first CRISPR therapy

An advisory committee is meeting to discuss the potential approval of exagamglogene autotemcel, a CRISPR-based gene editing therapy candidate for sickle cell disease.

F.D.A. Experts Will Vote on Safety of a Cure for Sickle Cell Disease - Vimarsana News

F.D.A. Experts Will Vote on Safety of a Cure for Sickle Cell Disease

The treatment from the company Vertex would be the first medicine to use the gene editing tool CRISPR.

Is retroelement-based gene editing a safer alternative to CRISPR-Cas approaches? - Vimarsana News

Is retroelement-based gene editing a safer alternative to CRISPR-Cas approaches?

In a Perspective, Stephen Tang and Samuel Sternberg discuss retroelement-based gene editing as a safer alternative to CRISPR-Cas approaches.

Novel replacement strategy holds promise for the treatment of various genetic disorders - Vimarsana News

Novel replacement strategy holds promise for the treatment of various genetic disorders

Severe Combined Immunodeficiencies (SCIDs) are a group of debilitating primary immunodeficiency disorders, primarily caused by genetic mutations that disrupt T-cell development. SCID can also affect B-cell and natural killer cell function and counts.